loadpatents
name:-0.032044887542725
name:-0.024499893188477
name:-0.029580116271973
Jessing; Mikkel Patent Filings

Jessing; Mikkel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jessing; Mikkel.The latest application filed is for "imidazopyrazinones as pde1 inhibitors".

Company Profile
31.25.36
  • Jessing; Mikkel - Frederiksberg DK
  • Jessing; Mikkel - Fredriksberg DK
  • Jessing; Mikkel - Valby DK
  • Jessing; Mikkel - Kobenhavn O DK
  • Jessing; Mikkel - Kobenhavn c DK
  • Jessing; Mikkel - Kobenhavn DK
  • Jessing; Mikkel - KobenhavnO DK
  • Jessing; Mikkel - Kobenhavn NV DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
Grant 11,104,680 - Juhl , et al. August 31, 2
2021-08-31
Imidazopyrazinones As Pde1 Inhibitors
App 20210238182 - Kehler; Jan ;   et al.
2021-08-05
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 11,026,923 - Kehler , et al. June 8, 2
2021-06-08
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 11,026,924 - Kehler , et al. June 8, 2
2021-06-08
Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors
Grant 10,912,773 - Kehler , et al. February 9, 2
2021-02-09
Combinations comprising substituted imidazo[1,5-.alpha.]pyrazinones as PDE1 inhibitors
Grant 10,905,688 - Kehler , et al. February 2, 2
2021-02-02
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20210023056 - Kehler; Jan ;   et al.
2021-01-28
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20210015794 - Kehler; Jan ;   et al.
2021-01-21
Pyrazolo[3,4-b]pyridines And Imidazo[1,5-b]pyridazines As Pde1 Inhibitors
App 20210009571 - Kehler; Jan ;   et al.
2021-01-14
Combination Treatments Comprising Administration Of 1h-pyrazolo[4,3-b]pyridines
App 20200385381 - Kehler; Jan ;   et al.
2020-12-10
Combination Treatments Comprising Administration Of 1h-pyrazolo[4,3-b]pyridines
App 20200385372 - Kehler; Jan ;   et al.
2020-12-10
Imidazopyrazinones as PDE1 inhibitors
Grant 10,858,362 - Kehler , et al. December 8, 2
2020-12-08
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20200375950 - Kehler; Jan ;   et al.
2020-12-03
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20200360343 - Kehler; Jan ;   et al.
2020-11-19
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 10,806,718 - Kehler , et al. October 20, 2
2020-10-20
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 10,766,893 - Juhl , et al. Sep
2020-09-08
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
Grant 10,689,379 - Kehler , et al.
2020-06-23
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20200129480 - Kehler; Jan ;   et al.
2020-04-30
Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors
Grant 10,633,382 - Kehler , et al.
2020-04-28
Macrocycles as PDE1 inhibitors
Grant 10,618,913 - Juhl , et al.
2020-04-14
1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-ones And 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-ones As Pde1 Inhibitors
App 20200102316 - Juhl; Karsten ;   et al.
2020-04-02
Benzamides-containing Compounds And Their Use In The Treatment Of Depression
App 20200054630 - KILBURN; JOHN PAUL ;   et al.
2020-02-20
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
Grant 10,538,525 - Juhl , et al. Ja
2020-01-21
1 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitors
Grant 10,512,632 - Kehler , et al. Dec
2019-12-24
Pyrazolo[3,4-b]pyridines And Imidazo[1,5-b]pyridazines As Pde1 Inhibitors
App 20190352302 - Kehler; Jan ;   et al.
2019-11-21
Imidazopyrazinones, Pyrazolopyrimidinones And Pyrazolopyridinones As Pde1 Inhibitors
App 20190308968 - Kehler; Jan ;   et al.
2019-10-10
Cyclic Amines
App 20190307766 - KILBURN; JOHN PAUL ;   et al.
2019-10-10
Combination Treatments Comprising Administration Of Imidazopyrazinones
App 20190282572 - Kehler; Jan ;   et al.
2019-09-19
Combination Treatments Comprising Administration Of Imidazopyrazinones
App 20190282571 - Kehler; Jan ;   et al.
2019-09-19
Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitors
Grant 10,351,561 - Kehler , et al. July 16, 2
2019-07-16
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20190194189 - Juhl; Karsten ;   et al.
2019-06-27
1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-ones And 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-ones As Pde1 Inhibitors
App 20190194204 - Juhl; Karsten ;   et al.
2019-06-27
Macrocycles As Pde1 Inhibitors
App 20190185489 - Juhl; Karsten ;   et al.
2019-06-20
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20190105302 - Kehler; Jan ;   et al.
2019-04-11
Benzamides-containing compounds and their use in the treatment of epilepsy
Grant 10,238,654 - Kilburn , et al.
2019-03-26
Imidazopyrazinones As Pde1 Inhibitors
App 20190062335 - Kehler; Jan ;   et al.
2019-02-28
Triazolopyrazinones as PDE1 inhibitors
Grant 10,150,771 - Kehler , et al. Dec
2018-12-11
Cyclic amines
Grant 10,124,010 - Kilburn , et al. November 13, 2
2018-11-13
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 10,034,861 - Kehler , et al. July 31, 2
2018-07-31
Imidazopyrazinones as PDE1 inhibitors
Grant 10,011,606 - Kehler , et al. July 3, 2
2018-07-03
PYRAZOLO[3,4-b]PYRIDINES AND IMIDAZO[1,5-b]PYRIDAZINES AS PDE1 INHIBITORS
App 20180179200 - Kehler; Jan ;   et al.
2018-06-28
Cyclic Amines
App 20180177793 - Kilburn; John Paul ;   et al.
2018-06-28
Cyclic amines
Grant 9,861,639 - Kilburn , et al. January 9, 2
2018-01-09
1H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
App 20180000786 - Kehler; Jan ;   et al.
2018-01-04
Triazolopyrazinones as PDE1 Inhibitors
App 20170298072 - Kehler; Jan ;   et al.
2017-10-19
Imidazopyrazinones as PDE1 Inhibitors
App 20170291903 - Kehler; Jan ;   et al.
2017-10-12
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 Inhibitors
App 20170291901 - Juhl; Karsten ;   et al.
2017-10-12
Benzamides-Containing Compounds and Their Use in the Treatment of Epilepsy
App 20170202836 - Kilburn; John Paul ;   et al.
2017-07-20
Benzamide-containing compounds and their use in the treatment of pain
Grant 9,649,308 - Kilburn , et al. May 16, 2
2017-05-16
Cyclic Amines
App 20170128460 - Kilburn; John Paul ;   et al.
2017-05-11
Cyclic amines
Grant 9,593,105 - Kilburn , et al. March 14, 2
2017-03-14
Cyclic Amines
App 20170008898 - Kilburn; John Paul ;   et al.
2017-01-12
Imidazopyrazinones as PDE1 Inhibitors
App 20160318939 - Kehler; Jan ;   et al.
2016-11-03
Imidazotriazinones as PDE1 Inhibitors
App 20160311831 - Kehler; Jan ;   et al.
2016-10-27
Cyclic amines
Grant 9,415,055 - Kilburn , et al. August 16, 2
2016-08-16
Cyclic Amines
App 20150306114 - Kilburn; John Paul ;   et al.
2015-10-29
Benzamides
App 20150283134 - Kilburn; John Paul ;   et al.
2015-10-08
Cyclic amines
Grant 9,108,938 - Kilburn , et al. August 18, 2
2015-08-18
Benzamides
Grant 9,102,591 - Kilburn , et al. August 11, 2
2015-08-11
Cyclic Amines
App 20140107335 - Kilburn; John Paul ;   et al.
2014-04-17
Benzamides
App 20140107340 - Kilburn; John Paul ;   et al.
2014-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed